Reneo Pharmaceuticals, Inc.

NASDAQ:RPHM

18.2 (USD) • At close October 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 35.9720.37527.63211.7379.08130.39519.92762.132118.264121.094124.66126.409140.36891.22153.613-24.887
Short Term Investments 40.70462.4675.331113.877133.59663.39281.24653.9488.58817.56823.0131.32526.9630049.774
Cash and Short Term Investments 76.67482.835102.963125.614142.67793.787101.173116.08126.852138.662147.67157.734167.33191.22153.61324.887
Net Receivables 0000000000000000
Inventory 0000000000000000
Other Current Assets 1.3161.0923.6593.1583.6433.2315.189.83610.3188.10612.1289.8627.624.6781.4120
Total Current Assets 77.9983.927106.622128.772146.3297.018106.353120.998132.011142.715153.734162.665171.14193.5655.02524.887
Non-Current Assets:
Property, Plant & Equipment, Net 0.5740.6480.7331.5351.641.7691.7451.4271.5191.6190.2120.20.0850.0810.0690
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 0000000000000000
Tax Assets 0000000000000000
Other Non-Current Assets 0.1530.0640.0810.0810.0790.0810.0840.0790.0780.0780.0780.0780.0781.680.127-24.887
Total Non-Current Assets 0.7270.7120.8141.6161.7191.851.8291.5061.5971.6970.290.2780.1631.7610.196-24.887
Total Assets 78.71784.639107.436130.388148.03998.868108.182122.504133.608144.412154.024162.943171.30495.32155.2210
Liabilities & Equity:
Current Liabilities:
Account Payables 0.0640.6768.7172.4731.8281.8021.8932.1891.561.5662.0221.2710.4340.5560.9080
Short Term Debt 0.6620.6620.6620.650.6360.7260.4040.820.8160.914000000
Tax Payables 0000000000000000
Deferred Revenue 00000000-0.4080000000
Other Current Liabilities 0.6221.4768.79810.4411.2747.9534.8276.4415.9595.434.185.0822.9023.3743.6720
Total Current Liabilities 1.3482.81418.17713.56313.73810.4817.1249.458.3357.916.2026.3533.3363.934.580
Non-Current Liabilities:
Long Term Debt 0.4920.5760.6420.8120.8970.9791.0590.9431.0611.127000000
Deferred Revenue Non-Current 00000000000.1670.0980.0540.03200
Deferred Tax Liabilities Non-Current 0000000000000-140.10800
Other Non-Current Liabilities 0.0080.0070.0071.0690.8760.3240.0290.0660.0550.0570.6110.3820.417140.10892.7560
Total Non-Current Liabilities 0.50.5830.6491.8811.7731.3031.0881.0091.1161.1840.6110.3820.417140.10892.7560
Total Liabilities 1.8483.39718.82615.44415.51111.7848.21210.4599.4519.0946.8136.7353.753144.03897.3360
Equity:
Preferred Stock 00000000000162.943171.30445.65292.7245.652
Common Stock 0.0030.0030.0030.0030.0030.0030.0030.0030.0030.0030.0030.0030.003000
Retained Earnings -232.261-226.9-218.474-190.517-171.321-151.79-136.683-123.083-110.076-97.764-84.728-74.121-61.386-52.17-44.9580
Accumulated Other Comprehensive Income/Loss -0.013-0.0120.008-0.021-0.0310.012-0.043-0.0260.1680.0640.0340.0170.00500-23.127
Other Total Stockholders Equity 309.14308.151307.073305.479303.877238.859236.693235.151234.062233.015231.902230.309228.9293.453-89.8770
Total Shareholders Equity 76.86981.24288.61114.944132.52887.08499.97112.045124.157135.318147.211156.208167.551-48.717-42.11522.525
Total Equity 76.86981.24288.61114.944132.52887.08499.97112.045124.157135.318147.211156.208167.551-48.717-42.11522.525
Total Liabilities & Shareholders Equity 78.71784.639107.436130.388148.03998.868108.182122.504133.608144.412154.024162.943171.30495.32155.22122.525